May 27, 2022
The latest guidance for Paxlovid treatment following rebound reports; Dupixent gets a new approval; A new treatment is approved for plaque psoriasis; Update on the efficacy of a COVID-19 vaccine in those aged under 5; And the latest on Monkeypox.
May 20, 2022
The FDA decide to decline
COVID-19 treatment; Booster doses authorized for children; A direct
to consumer test to detect COVID-19, influenza, and RSV; And a
wearable furosemide delivery system accepted for
review.
May 12, 2022
Treatment approved for hospitalized COVID-19 patients; Update on Varenicline supply; Limits have been set for the Janssen COVID-19 vaccine; Safety alert issued for a COVID-19 test; And certain hemodialysis machines may carry the potential for chemical exposure.